nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—Glyburide—type 2 diabetes mellitus	0.351	1	CrCtD
Zafirlukast—CYP2E1—type 2 diabetes mellitus	0.0507	0.387	CbGaD
Zafirlukast—Glyburide—Tolazamide—type 2 diabetes mellitus	0.0485	0.21	CrCrCtD
Zafirlukast—Glyburide—Glimepiride—type 2 diabetes mellitus	0.0485	0.21	CrCrCtD
Zafirlukast—CYP1A2—type 2 diabetes mellitus	0.0482	0.369	CbGaD
Zafirlukast—Glyburide—Gliclazide—type 2 diabetes mellitus	0.0459	0.199	CrCrCtD
Zafirlukast—Glyburide—Glipizide—type 2 diabetes mellitus	0.0459	0.199	CrCrCtD
Zafirlukast—Glyburide—Chlorpropamide—type 2 diabetes mellitus	0.042	0.182	CrCrCtD
Zafirlukast—CYP3A4—type 2 diabetes mellitus	0.0319	0.244	CbGaD
Zafirlukast—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.00955	0.0479	CbGbCtD
Zafirlukast—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.00955	0.0479	CbGbCtD
Zafirlukast—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.00881	0.0442	CbGbCtD
Zafirlukast—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.00762	0.0382	CbGbCtD
Zafirlukast—PTGS1—Nateglinide—type 2 diabetes mellitus	0.00724	0.0363	CbGbCtD
Zafirlukast—PTGS1—Irbesartan—type 2 diabetes mellitus	0.00694	0.0348	CbGbCtD
Zafirlukast—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00609	0.0305	CbGbCtD
Zafirlukast—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00551	0.0276	CbGbCtD
Zafirlukast—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00544	0.0273	CbGbCtD
Zafirlukast—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00532	0.0267	CbGbCtD
Zafirlukast—ABCG2—Glyburide—type 2 diabetes mellitus	0.0053	0.0265	CbGbCtD
Zafirlukast—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.00509	0.0255	CbGbCtD
Zafirlukast—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00491	0.0246	CbGbCtD
Zafirlukast—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00486	0.0244	CbGbCtD
Zafirlukast—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00462	0.0232	CbGbCtD
Zafirlukast—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00462	0.0232	CbGbCtD
Zafirlukast—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00452	0.0227	CbGbCtD
Zafirlukast—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00427	0.0214	CbGbCtD
Zafirlukast—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00412	0.0207	CbGbCtD
Zafirlukast—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.004	0.0201	CbGbCtD
Zafirlukast—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00394	0.0197	CbGbCtD
Zafirlukast—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00384	0.0193	CbGbCtD
Zafirlukast—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00384	0.0193	CbGbCtD
Zafirlukast—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00355	0.0178	CbGbCtD
Zafirlukast—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00352	0.0176	CbGbCtD
Zafirlukast—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00347	0.0174	CbGbCtD
Zafirlukast—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00343	0.0172	CbGbCtD
Zafirlukast—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00324	0.0163	CbGbCtD
Zafirlukast—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00313	0.0157	CbGbCtD
Zafirlukast—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0031	0.0155	CbGbCtD
Zafirlukast—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00309	0.0155	CbGbCtD
Zafirlukast—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00293	0.0147	CbGbCtD
Zafirlukast—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00291	0.0146	CbGbCtD
Zafirlukast—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00283	0.0142	CbGbCtD
Zafirlukast—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00279	0.014	CbGbCtD
Zafirlukast—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00266	0.0134	CbGbCtD
Zafirlukast—CYP2C8—Losartan—type 2 diabetes mellitus	0.00258	0.0129	CbGbCtD
Zafirlukast—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00255	0.0128	CbGbCtD
Zafirlukast—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00247	0.0124	CbGbCtD
Zafirlukast—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00237	0.0119	CbGbCtD
Zafirlukast—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00224	0.0112	CbGbCtD
Zafirlukast—CYP2C19—Losartan—type 2 diabetes mellitus	0.00217	0.0109	CbGbCtD
Zafirlukast—CYP1A2—Losartan—type 2 diabetes mellitus	0.002	0.01	CbGbCtD
Zafirlukast—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00197	0.00986	CbGbCtD
Zafirlukast—CYP2C9—Losartan—type 2 diabetes mellitus	0.0018	0.00902	CbGbCtD
Zafirlukast—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00169	0.00849	CbGbCtD
Zafirlukast—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00162	0.00814	CbGbCtD
Zafirlukast—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00162	0.00814	CbGbCtD
Zafirlukast—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00154	0.0077	CbGbCtD
Zafirlukast—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00114	0.00574	CbGbCtD
Zafirlukast—CYP3A4—Losartan—type 2 diabetes mellitus	0.00105	0.00525	CbGbCtD
Zafirlukast—Glyburide—CPT1A—type 2 diabetes mellitus	0.000413	0.328	CrCbGaD
Zafirlukast—Glyburide—ABCC8—type 2 diabetes mellitus	0.000286	0.227	CrCbGaD
Zafirlukast—Glyburide—KCNJ11—type 2 diabetes mellitus	0.000202	0.16	CrCbGaD
Zafirlukast—Tolvaptan—CYP3A4—type 2 diabetes mellitus	0.00016	0.127	CrCbGaD
Zafirlukast—CYSLTR2—cardiovascular system—type 2 diabetes mellitus	0.000157	0.256	CbGeAlD
Zafirlukast—Glyburide—ABCC2—type 2 diabetes mellitus	0.000109	0.0865	CrCbGaD
Zafirlukast—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	5.79e-05	0.00106	CcSEcCtD
Zafirlukast—Angioedema—Orlistat—type 2 diabetes mellitus	5.76e-05	0.00105	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	5.75e-05	0.00105	CcSEcCtD
Zafirlukast—CYSLTR1—pancreas—type 2 diabetes mellitus	5.73e-05	0.0937	CbGeAlD
Zafirlukast—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	5.69e-05	0.00104	CcSEcCtD
Zafirlukast—Malaise—Orlistat—type 2 diabetes mellitus	5.68e-05	0.00104	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	5.64e-05	0.00103	CcSEcCtD
Zafirlukast—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	5.64e-05	0.00103	CcSEcCtD
Zafirlukast—Asthenia—Pioglitazone—type 2 diabetes mellitus	5.63e-05	0.00103	CcSEcCtD
Zafirlukast—Infection—Gliclazide—type 2 diabetes mellitus	5.63e-05	0.00103	CcSEcCtD
Zafirlukast—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	5.62e-05	0.00103	CcSEcCtD
Zafirlukast—Diarrhoea—Glipizide—type 2 diabetes mellitus	5.61e-05	0.00103	CcSEcCtD
Zafirlukast—Nausea—Rosiglitazone—type 2 diabetes mellitus	5.56e-05	0.00102	CcSEcCtD
Zafirlukast—Dyspepsia—Glyburide—type 2 diabetes mellitus	5.55e-05	0.00102	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	5.55e-05	0.00101	CcSEcCtD
Zafirlukast—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	5.55e-05	0.00101	CcSEcCtD
Zafirlukast—Jaundice—Ramipril—type 2 diabetes mellitus	5.52e-05	0.00101	CcSEcCtD
Zafirlukast—Asthenia—Glimepiride—type 2 diabetes mellitus	5.49e-05	0.001	CcSEcCtD
Zafirlukast—Urticaria—Bromocriptine—type 2 diabetes mellitus	5.48e-05	0.001	CcSEcCtD
Zafirlukast—Asthenia—Sitagliptin—type 2 diabetes mellitus	5.47e-05	0.001	CcSEcCtD
Zafirlukast—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	5.46e-05	0.000998	CcSEcCtD
Zafirlukast—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	5.46e-05	0.000998	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	5.45e-05	0.000996	CcSEcCtD
Zafirlukast—Myalgia—Valsartan—type 2 diabetes mellitus	5.43e-05	0.000993	CcSEcCtD
Zafirlukast—Arthralgia—Valsartan—type 2 diabetes mellitus	5.43e-05	0.000993	CcSEcCtD
Zafirlukast—Dizziness—Glipizide—type 2 diabetes mellitus	5.42e-05	0.000991	CcSEcCtD
Zafirlukast—Pruritus—Glimepiride—type 2 diabetes mellitus	5.41e-05	0.00099	CcSEcCtD
Zafirlukast—Ill-defined disorder—Metformin—type 2 diabetes mellitus	5.39e-05	0.000985	CcSEcCtD
Zafirlukast—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	5.37e-05	0.000983	CcSEcCtD
Zafirlukast—Myalgia—Orlistat—type 2 diabetes mellitus	5.37e-05	0.000981	CcSEcCtD
Zafirlukast—Sinusitis—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000971	CcSEcCtD
Zafirlukast—Discomfort—Orlistat—type 2 diabetes mellitus	5.3e-05	0.000969	CcSEcCtD
Zafirlukast—Agranulocytosis—Ramipril—type 2 diabetes mellitus	5.28e-05	0.000966	CcSEcCtD
Zafirlukast—Malaise—Metformin—type 2 diabetes mellitus	5.24e-05	0.000958	CcSEcCtD
Zafirlukast—Diarrhoea—Glimepiride—type 2 diabetes mellitus	5.23e-05	0.000957	CcSEcCtD
Zafirlukast—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	5.22e-05	0.000954	CcSEcCtD
Zafirlukast—Vomiting—Glipizide—type 2 diabetes mellitus	5.21e-05	0.000953	CcSEcCtD
Zafirlukast—Oedema—Valsartan—type 2 diabetes mellitus	5.21e-05	0.000952	CcSEcCtD
Zafirlukast—CYSLTR1—adipose tissue—type 2 diabetes mellitus	5.2e-05	0.085	CbGeAlD
Zafirlukast—Feeling abnormal—Glyburide—type 2 diabetes mellitus	5.2e-05	0.000951	CcSEcCtD
Zafirlukast—Dizziness—Pioglitazone—type 2 diabetes mellitus	5.19e-05	0.00095	CcSEcCtD
Zafirlukast—Infection—Valsartan—type 2 diabetes mellitus	5.17e-05	0.000946	CcSEcCtD
Zafirlukast—Rash—Glipizide—type 2 diabetes mellitus	5.17e-05	0.000945	CcSEcCtD
Zafirlukast—Dermatitis—Glipizide—type 2 diabetes mellitus	5.16e-05	0.000944	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	5.16e-05	0.000944	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	5.16e-05	0.000943	CcSEcCtD
Zafirlukast—Oedema—Orlistat—type 2 diabetes mellitus	5.14e-05	0.000941	CcSEcCtD
Zafirlukast—Headache—Glipizide—type 2 diabetes mellitus	5.14e-05	0.000939	CcSEcCtD
Zafirlukast—Insomnia—Gliclazide—type 2 diabetes mellitus	5.12e-05	0.000937	CcSEcCtD
Zafirlukast—Infection—Orlistat—type 2 diabetes mellitus	5.11e-05	0.000934	CcSEcCtD
Zafirlukast—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	5.1e-05	0.000932	CcSEcCtD
Zafirlukast—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	5.09e-05	0.00093	CcSEcCtD
Zafirlukast—Hepatitis—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000929	CcSEcCtD
Zafirlukast—Dizziness—Glimepiride—type 2 diabetes mellitus	5.06e-05	0.000925	CcSEcCtD
Zafirlukast—Dizziness—Sitagliptin—type 2 diabetes mellitus	5.04e-05	0.000922	CcSEcCtD
Zafirlukast—Urticaria—Glyburide—type 2 diabetes mellitus	5.01e-05	0.000917	CcSEcCtD
Zafirlukast—Angioedema—Irbesartan—type 2 diabetes mellitus	5.01e-05	0.000916	CcSEcCtD
Zafirlukast—Back pain—Losartan—type 2 diabetes mellitus	4.99e-05	0.000912	CcSEcCtD
Zafirlukast—Abdominal pain—Glyburide—type 2 diabetes mellitus	4.99e-05	0.000912	CcSEcCtD
Zafirlukast—Dyspepsia—Gliclazide—type 2 diabetes mellitus	4.99e-05	0.000912	CcSEcCtD
Zafirlukast—Asthenia—Bromocriptine—type 2 diabetes mellitus	4.95e-05	0.000906	CcSEcCtD
Zafirlukast—Myalgia—Metformin—type 2 diabetes mellitus	4.94e-05	0.000904	CcSEcCtD
Zafirlukast—Malaise—Irbesartan—type 2 diabetes mellitus	4.94e-05	0.000904	CcSEcCtD
Zafirlukast—Headache—Pioglitazone—type 2 diabetes mellitus	4.92e-05	0.0009	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	4.89e-05	0.000894	CcSEcCtD
Zafirlukast—Discomfort—Metformin—type 2 diabetes mellitus	4.89e-05	0.000893	CcSEcCtD
Zafirlukast—Fatigue—Gliclazide—type 2 diabetes mellitus	4.88e-05	0.000893	CcSEcCtD
Zafirlukast—Nausea—Glipizide—type 2 diabetes mellitus	4.87e-05	0.00089	CcSEcCtD
Zafirlukast—Vomiting—Glimepiride—type 2 diabetes mellitus	4.86e-05	0.00089	CcSEcCtD
Zafirlukast—Vomiting—Sitagliptin—type 2 diabetes mellitus	4.85e-05	0.000887	CcSEcCtD
Zafirlukast—Pain—Gliclazide—type 2 diabetes mellitus	4.84e-05	0.000886	CcSEcCtD
Zafirlukast—Rash—Glimepiride—type 2 diabetes mellitus	4.82e-05	0.000882	CcSEcCtD
Zafirlukast—Glyburide—CYP3A4—type 2 diabetes mellitus	4.82e-05	0.0382	CrCbGaD
Zafirlukast—Dermatitis—Glimepiride—type 2 diabetes mellitus	4.82e-05	0.000881	CcSEcCtD
Zafirlukast—Rash—Sitagliptin—type 2 diabetes mellitus	4.81e-05	0.000879	CcSEcCtD
Zafirlukast—Dermatitis—Sitagliptin—type 2 diabetes mellitus	4.8e-05	0.000879	CcSEcCtD
Zafirlukast—Headache—Glimepiride—type 2 diabetes mellitus	4.79e-05	0.000876	CcSEcCtD
Zafirlukast—Ill-defined disorder—Losartan—type 2 diabetes mellitus	4.79e-05	0.000875	CcSEcCtD
Zafirlukast—Headache—Sitagliptin—type 2 diabetes mellitus	4.78e-05	0.000874	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	4.74e-05	0.000867	CcSEcCtD
Zafirlukast—Oedema—Metformin—type 2 diabetes mellitus	4.74e-05	0.000867	CcSEcCtD
Zafirlukast—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	4.72e-05	0.000864	CcSEcCtD
Zafirlukast—Angioedema—Losartan—type 2 diabetes mellitus	4.71e-05	0.000862	CcSEcCtD
Zafirlukast—Infection—Metformin—type 2 diabetes mellitus	4.71e-05	0.000861	CcSEcCtD
Zafirlukast—Insomnia—Valsartan—type 2 diabetes mellitus	4.71e-05	0.000861	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	4.69e-05	0.000857	CcSEcCtD
Zafirlukast—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	4.67e-05	0.000854	CcSEcCtD
Zafirlukast—Arthralgia—Irbesartan—type 2 diabetes mellitus	4.67e-05	0.000853	CcSEcCtD
Zafirlukast—Myalgia—Irbesartan—type 2 diabetes mellitus	4.67e-05	0.000853	CcSEcCtD
Zafirlukast—Insomnia—Orlistat—type 2 diabetes mellitus	4.65e-05	0.000851	CcSEcCtD
Zafirlukast—Malaise—Losartan—type 2 diabetes mellitus	4.65e-05	0.000851	CcSEcCtD
Zafirlukast—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.65e-05	0.00085	CcSEcCtD
Zafirlukast—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4.64e-05	0.000849	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.63e-05	0.000847	CcSEcCtD
Zafirlukast—Discomfort—Irbesartan—type 2 diabetes mellitus	4.61e-05	0.000843	CcSEcCtD
Zafirlukast—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.58e-05	0.000838	CcSEcCtD
Zafirlukast—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.56e-05	0.000835	CcSEcCtD
Zafirlukast—Nausea—Glimepiride—type 2 diabetes mellitus	4.54e-05	0.000831	CcSEcCtD
Zafirlukast—Nausea—Sitagliptin—type 2 diabetes mellitus	4.53e-05	0.000828	CcSEcCtD
Zafirlukast—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.53e-05	0.000828	CcSEcCtD
Zafirlukast—Asthenia—Glyburide—type 2 diabetes mellitus	4.53e-05	0.000828	CcSEcCtD
Zafirlukast—Urticaria—Gliclazide—type 2 diabetes mellitus	4.5e-05	0.000823	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.49e-05	0.000822	CcSEcCtD
Zafirlukast—Fatigue—Valsartan—type 2 diabetes mellitus	4.49e-05	0.000821	CcSEcCtD
Zafirlukast—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.48e-05	0.000819	CcSEcCtD
Zafirlukast—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.48e-05	0.000819	CcSEcCtD
Zafirlukast—Oedema—Irbesartan—type 2 diabetes mellitus	4.47e-05	0.000818	CcSEcCtD
Zafirlukast—Pruritus—Glyburide—type 2 diabetes mellitus	4.46e-05	0.000816	CcSEcCtD
Zafirlukast—Infection—Irbesartan—type 2 diabetes mellitus	4.44e-05	0.000813	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.44e-05	0.000812	CcSEcCtD
Zafirlukast—Fatigue—Orlistat—type 2 diabetes mellitus	4.43e-05	0.000811	CcSEcCtD
Zafirlukast—Pain—Orlistat—type 2 diabetes mellitus	4.4e-05	0.000804	CcSEcCtD
Zafirlukast—Myalgia—Losartan—type 2 diabetes mellitus	4.39e-05	0.000803	CcSEcCtD
Zafirlukast—Arthralgia—Losartan—type 2 diabetes mellitus	4.39e-05	0.000803	CcSEcCtD
Zafirlukast—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.39e-05	0.000802	CcSEcCtD
Zafirlukast—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.38e-05	0.000801	CcSEcCtD
Zafirlukast—Rash—Bromocriptine—type 2 diabetes mellitus	4.35e-05	0.000796	CcSEcCtD
Zafirlukast—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.35e-05	0.000795	CcSEcCtD
Zafirlukast—Discomfort—Losartan—type 2 diabetes mellitus	4.34e-05	0.000793	CcSEcCtD
Zafirlukast—Headache—Bromocriptine—type 2 diabetes mellitus	4.32e-05	0.000791	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.32e-05	0.00079	CcSEcCtD
Zafirlukast—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.32e-05	0.000789	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.26e-05	0.000778	CcSEcCtD
Zafirlukast—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.24e-05	0.000775	CcSEcCtD
Zafirlukast—Oedema—Losartan—type 2 diabetes mellitus	4.21e-05	0.00077	CcSEcCtD
Zafirlukast—Glyburide—ALB—type 2 diabetes mellitus	4.21e-05	0.0334	CrCbGaD
Zafirlukast—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.21e-05	0.000769	CcSEcCtD
Zafirlukast—Infection—Losartan—type 2 diabetes mellitus	4.18e-05	0.000765	CcSEcCtD
Zafirlukast—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.17e-05	0.000763	CcSEcCtD
Zafirlukast—Dyspepsia—Metformin—type 2 diabetes mellitus	4.17e-05	0.000763	CcSEcCtD
Zafirlukast—Urticaria—Valsartan—type 2 diabetes mellitus	4.14e-05	0.000756	CcSEcCtD
Zafirlukast—PTGS1—artery—type 2 diabetes mellitus	4.13e-05	0.0674	CbGeAlD
Zafirlukast—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.12e-05	0.000754	CcSEcCtD
Zafirlukast—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.11e-05	0.000752	CcSEcCtD
Zafirlukast—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.1e-05	0.00075	CcSEcCtD
Zafirlukast—Nausea—Bromocriptine—type 2 diabetes mellitus	4.1e-05	0.00075	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.09e-05	0.000748	CcSEcCtD
Zafirlukast—Fatigue—Metformin—type 2 diabetes mellitus	4.09e-05	0.000747	CcSEcCtD
Zafirlukast—Urticaria—Orlistat—type 2 diabetes mellitus	4.09e-05	0.000747	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.08e-05	0.000745	CcSEcCtD
Zafirlukast—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.07e-05	0.000744	CcSEcCtD
Zafirlukast—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.07e-05	0.000744	CcSEcCtD
Zafirlukast—Asthenia—Gliclazide—type 2 diabetes mellitus	4.06e-05	0.000743	CcSEcCtD
Zafirlukast—Angioedema—Ramipril—type 2 diabetes mellitus	4.04e-05	0.000739	CcSEcCtD
Zafirlukast—Vomiting—Glyburide—type 2 diabetes mellitus	4.01e-05	0.000734	CcSEcCtD
Zafirlukast—Pruritus—Gliclazide—type 2 diabetes mellitus	4.01e-05	0.000733	CcSEcCtD
Zafirlukast—Malaise—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000729	CcSEcCtD
Zafirlukast—Rash—Glyburide—type 2 diabetes mellitus	3.98e-05	0.000727	CcSEcCtD
Zafirlukast—Dermatitis—Glyburide—type 2 diabetes mellitus	3.97e-05	0.000727	CcSEcCtD
Zafirlukast—Headache—Glyburide—type 2 diabetes mellitus	3.95e-05	0.000723	CcSEcCtD
Zafirlukast—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.94e-05	0.00072	CcSEcCtD
Zafirlukast—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.91e-05	0.000714	CcSEcCtD
Zafirlukast—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.88e-05	0.000709	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	3.88e-05	0.000709	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	3.86e-05	0.000706	CcSEcCtD
Zafirlukast—Fatigue—Irbesartan—type 2 diabetes mellitus	3.86e-05	0.000705	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.84e-05	0.000701	CcSEcCtD
Zafirlukast—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.83e-05	0.000701	CcSEcCtD
Zafirlukast—Pain—Irbesartan—type 2 diabetes mellitus	3.83e-05	0.0007	CcSEcCtD
Zafirlukast—Insomnia—Losartan—type 2 diabetes mellitus	3.81e-05	0.000696	CcSEcCtD
Zafirlukast—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.79e-05	0.000693	CcSEcCtD
Zafirlukast—Urticaria—Metformin—type 2 diabetes mellitus	3.77e-05	0.000689	CcSEcCtD
Zafirlukast—Arthralgia—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000689	CcSEcCtD
Zafirlukast—Myalgia—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000689	CcSEcCtD
Zafirlukast—Nausea—Glyburide—type 2 diabetes mellitus	3.75e-05	0.000685	CcSEcCtD
Zafirlukast—Abdominal pain—Metformin—type 2 diabetes mellitus	3.75e-05	0.000685	CcSEcCtD
Zafirlukast—Dizziness—Gliclazide—type 2 diabetes mellitus	3.75e-05	0.000685	CcSEcCtD
Zafirlukast—Asthenia—Valsartan—type 2 diabetes mellitus	3.73e-05	0.000683	CcSEcCtD
Zafirlukast—Discomfort—Ramipril—type 2 diabetes mellitus	3.72e-05	0.00068	CcSEcCtD
Zafirlukast—Dyspepsia—Losartan—type 2 diabetes mellitus	3.71e-05	0.000678	CcSEcCtD
Zafirlukast—Asthenia—Orlistat—type 2 diabetes mellitus	3.69e-05	0.000675	CcSEcCtD
Zafirlukast—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.69e-05	0.000674	CcSEcCtD
Zafirlukast—Pruritus—Valsartan—type 2 diabetes mellitus	3.68e-05	0.000673	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.66e-05	0.000669	CcSEcCtD
Zafirlukast—Pruritus—Orlistat—type 2 diabetes mellitus	3.64e-05	0.000665	CcSEcCtD
Zafirlukast—Fatigue—Losartan—type 2 diabetes mellitus	3.63e-05	0.000664	CcSEcCtD
Zafirlukast—Oedema—Ramipril—type 2 diabetes mellitus	3.61e-05	0.00066	CcSEcCtD
Zafirlukast—Vomiting—Gliclazide—type 2 diabetes mellitus	3.6e-05	0.000659	CcSEcCtD
Zafirlukast—Pain—Losartan—type 2 diabetes mellitus	3.6e-05	0.000658	CcSEcCtD
Zafirlukast—Rash—Gliclazide—type 2 diabetes mellitus	3.57e-05	0.000653	CcSEcCtD
Zafirlukast—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.57e-05	0.000653	CcSEcCtD
Zafirlukast—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.56e-05	0.000651	CcSEcCtD
Zafirlukast—Urticaria—Irbesartan—type 2 diabetes mellitus	3.55e-05	0.00065	CcSEcCtD
Zafirlukast—Headache—Gliclazide—type 2 diabetes mellitus	3.55e-05	0.000649	CcSEcCtD
Zafirlukast—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.54e-05	0.000647	CcSEcCtD
Zafirlukast—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.54e-05	0.000647	CcSEcCtD
Zafirlukast—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.53e-05	0.000646	CcSEcCtD
Zafirlukast—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.52e-05	0.000644	CcSEcCtD
Zafirlukast—PTGS1—endothelium—type 2 diabetes mellitus	3.48e-05	0.0569	CbGeAlD
Zafirlukast—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.47e-05	0.000634	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.44e-05	0.00063	CcSEcCtD
Zafirlukast—Dizziness—Valsartan—type 2 diabetes mellitus	3.44e-05	0.000629	CcSEcCtD
Zafirlukast—Dizziness—Orlistat—type 2 diabetes mellitus	3.4e-05	0.000622	CcSEcCtD
Zafirlukast—Asthenia—Metformin—type 2 diabetes mellitus	3.4e-05	0.000622	CcSEcCtD
Zafirlukast—Nausea—Gliclazide—type 2 diabetes mellitus	3.37e-05	0.000615	CcSEcCtD
Zafirlukast—Pruritus—Metformin—type 2 diabetes mellitus	3.35e-05	0.000613	CcSEcCtD
Zafirlukast—Urticaria—Losartan—type 2 diabetes mellitus	3.34e-05	0.000612	CcSEcCtD
Zafirlukast—Abdominal pain—Losartan—type 2 diabetes mellitus	3.33e-05	0.000609	CcSEcCtD
Zafirlukast—Body temperature increased—Losartan—type 2 diabetes mellitus	3.33e-05	0.000609	CcSEcCtD
Zafirlukast—Vomiting—Valsartan—type 2 diabetes mellitus	3.31e-05	0.000605	CcSEcCtD
Zafirlukast—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.3e-05	0.000603	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.29e-05	0.000601	CcSEcCtD
Zafirlukast—Rash—Valsartan—type 2 diabetes mellitus	3.28e-05	0.0006	CcSEcCtD
Zafirlukast—Dermatitis—Valsartan—type 2 diabetes mellitus	3.28e-05	0.0006	CcSEcCtD
Zafirlukast—Vomiting—Orlistat—type 2 diabetes mellitus	3.27e-05	0.000598	CcSEcCtD
Zafirlukast—Insomnia—Ramipril—type 2 diabetes mellitus	3.26e-05	0.000597	CcSEcCtD
Zafirlukast—Headache—Valsartan—type 2 diabetes mellitus	3.26e-05	0.000596	CcSEcCtD
Zafirlukast—Diarrhoea—Metformin—type 2 diabetes mellitus	3.24e-05	0.000593	CcSEcCtD
Zafirlukast—Rash—Orlistat—type 2 diabetes mellitus	3.24e-05	0.000593	CcSEcCtD
Zafirlukast—Dermatitis—Orlistat—type 2 diabetes mellitus	3.24e-05	0.000592	CcSEcCtD
Zafirlukast—Headache—Orlistat—type 2 diabetes mellitus	3.22e-05	0.000589	CcSEcCtD
Zafirlukast—Asthenia—Irbesartan—type 2 diabetes mellitus	3.21e-05	0.000587	CcSEcCtD
Zafirlukast—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.18e-05	0.000581	CcSEcCtD
Zafirlukast—Pruritus—Irbesartan—type 2 diabetes mellitus	3.16e-05	0.000579	CcSEcCtD
Zafirlukast—Dizziness—Metformin—type 2 diabetes mellitus	3.13e-05	0.000573	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.12e-05	0.00057	CcSEcCtD
Zafirlukast—Fatigue—Ramipril—type 2 diabetes mellitus	3.11e-05	0.000569	CcSEcCtD
Zafirlukast—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.1e-05	0.000567	CcSEcCtD
Zafirlukast—Nausea—Valsartan—type 2 diabetes mellitus	3.09e-05	0.000565	CcSEcCtD
Zafirlukast—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.06e-05	0.00056	CcSEcCtD
Zafirlukast—Nausea—Orlistat—type 2 diabetes mellitus	3.06e-05	0.000559	CcSEcCtD
Zafirlukast—Asthenia—Losartan—type 2 diabetes mellitus	3.02e-05	0.000552	CcSEcCtD
Zafirlukast—Vomiting—Metformin—type 2 diabetes mellitus	3.01e-05	0.000551	CcSEcCtD
Zafirlukast—Rash—Metformin—type 2 diabetes mellitus	2.99e-05	0.000547	CcSEcCtD
Zafirlukast—Dermatitis—Metformin—type 2 diabetes mellitus	2.99e-05	0.000546	CcSEcCtD
Zafirlukast—Pruritus—Losartan—type 2 diabetes mellitus	2.98e-05	0.000545	CcSEcCtD
Zafirlukast—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000544	CcSEcCtD
Zafirlukast—Headache—Metformin—type 2 diabetes mellitus	2.97e-05	0.000543	CcSEcCtD
Zafirlukast—Dizziness—Irbesartan—type 2 diabetes mellitus	2.96e-05	0.000541	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.95e-05	0.00054	CcSEcCtD
Zafirlukast—Diarrhoea—Losartan—type 2 diabetes mellitus	2.88e-05	0.000527	CcSEcCtD
Zafirlukast—Urticaria—Ramipril—type 2 diabetes mellitus	2.87e-05	0.000524	CcSEcCtD
Zafirlukast—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000522	CcSEcCtD
Zafirlukast—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000522	CcSEcCtD
Zafirlukast—Vomiting—Irbesartan—type 2 diabetes mellitus	2.84e-05	0.00052	CcSEcCtD
Zafirlukast—Rash—Irbesartan—type 2 diabetes mellitus	2.82e-05	0.000516	CcSEcCtD
Zafirlukast—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.82e-05	0.000515	CcSEcCtD
Zafirlukast—Nausea—Metformin—type 2 diabetes mellitus	2.82e-05	0.000515	CcSEcCtD
Zafirlukast—Headache—Irbesartan—type 2 diabetes mellitus	2.8e-05	0.000512	CcSEcCtD
Zafirlukast—Dizziness—Losartan—type 2 diabetes mellitus	2.78e-05	0.000509	CcSEcCtD
Zafirlukast—Vomiting—Losartan—type 2 diabetes mellitus	2.68e-05	0.000489	CcSEcCtD
Zafirlukast—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.66e-05	0.000486	CcSEcCtD
Zafirlukast—Nausea—Irbesartan—type 2 diabetes mellitus	2.66e-05	0.000486	CcSEcCtD
Zafirlukast—Rash—Losartan—type 2 diabetes mellitus	2.65e-05	0.000485	CcSEcCtD
Zafirlukast—Dermatitis—Losartan—type 2 diabetes mellitus	2.65e-05	0.000485	CcSEcCtD
Zafirlukast—Headache—Losartan—type 2 diabetes mellitus	2.64e-05	0.000482	CcSEcCtD
Zafirlukast—Asthenia—Ramipril—type 2 diabetes mellitus	2.59e-05	0.000474	CcSEcCtD
Zafirlukast—Pruritus—Ramipril—type 2 diabetes mellitus	2.55e-05	0.000467	CcSEcCtD
Zafirlukast—Nausea—Losartan—type 2 diabetes mellitus	2.5e-05	0.000457	CcSEcCtD
Zafirlukast—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.47e-05	0.000452	CcSEcCtD
Zafirlukast—Dizziness—Ramipril—type 2 diabetes mellitus	2.39e-05	0.000437	CcSEcCtD
Zafirlukast—Vomiting—Ramipril—type 2 diabetes mellitus	2.3e-05	0.00042	CcSEcCtD
Zafirlukast—Rash—Ramipril—type 2 diabetes mellitus	2.28e-05	0.000416	CcSEcCtD
Zafirlukast—Dermatitis—Ramipril—type 2 diabetes mellitus	2.27e-05	0.000416	CcSEcCtD
Zafirlukast—Headache—Ramipril—type 2 diabetes mellitus	2.26e-05	0.000414	CcSEcCtD
Zafirlukast—Nausea—Ramipril—type 2 diabetes mellitus	2.14e-05	0.000392	CcSEcCtD
Zafirlukast—ABCG2—nephron tubule—type 2 diabetes mellitus	1.91e-05	0.0313	CbGeAlD
Zafirlukast—CYP2C8—kidney—type 2 diabetes mellitus	1.73e-05	0.0283	CbGeAlD
Zafirlukast—CYP2E1—nephron tubule—type 2 diabetes mellitus	1.66e-05	0.0271	CbGeAlD
Zafirlukast—CYP2C9—cardiovascular system—type 2 diabetes mellitus	1.57e-05	0.0257	CbGeAlD
Zafirlukast—ABCG2—adipose tissue—type 2 diabetes mellitus	1.52e-05	0.0248	CbGeAlD
Zafirlukast—CYP2E1—cardiovascular system—type 2 diabetes mellitus	1.49e-05	0.0243	CbGeAlD
Zafirlukast—CYP2E1—kidney—type 2 diabetes mellitus	1.46e-05	0.0238	CbGeAlD
Zafirlukast—PTGS1—cardiovascular system—type 2 diabetes mellitus	1.43e-05	0.0234	CbGeAlD
Zafirlukast—CYP2E1—cortex of kidney—type 2 diabetes mellitus	1.42e-05	0.0232	CbGeAlD
Zafirlukast—PTGS1—kidney—type 2 diabetes mellitus	1.4e-05	0.0229	CbGeAlD
Zafirlukast—PTGS1—adipose tissue—type 2 diabetes mellitus	1.26e-05	0.0207	CbGeAlD
Zafirlukast—CYP2C19—liver—type 2 diabetes mellitus	1.25e-05	0.0205	CbGeAlD
Zafirlukast—CYP3A4—kidney—type 2 diabetes mellitus	1.17e-05	0.0191	CbGeAlD
Zafirlukast—CYP2D6—kidney—type 2 diabetes mellitus	1.15e-05	0.0188	CbGeAlD
Zafirlukast—CYP2C8—liver—type 2 diabetes mellitus	1.09e-05	0.0179	CbGeAlD
Zafirlukast—ABCG2—liver—type 2 diabetes mellitus	1.06e-05	0.0174	CbGeAlD
Zafirlukast—CYP1A2—liver—type 2 diabetes mellitus	1.02e-05	0.0167	CbGeAlD
Zafirlukast—CYP2C9—liver—type 2 diabetes mellitus	9.71e-06	0.0159	CbGeAlD
Zafirlukast—CYP2E1—liver—type 2 diabetes mellitus	9.2e-06	0.015	CbGeAlD
Zafirlukast—CYP3A4—liver—type 2 diabetes mellitus	7.41e-06	0.0121	CbGeAlD
Zafirlukast—CYP2D6—liver—type 2 diabetes mellitus	7.29e-06	0.0119	CbGeAlD
Zafirlukast—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	1.51e-06	4.77e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	1.5e-06	4.75e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	1.5e-06	4.75e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.49e-06	4.73e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	1.49e-06	4.7e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	1.49e-06	4.7e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—INS—type 2 diabetes mellitus	1.48e-06	4.69e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.48e-06	4.68e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.48e-06	4.67e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.47e-06	4.67e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	1.47e-06	4.66e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.47e-06	4.66e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.46e-06	4.64e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	1.46e-06	4.63e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	1.46e-06	4.63e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	1.46e-06	4.63e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.46e-06	4.63e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	1.46e-06	4.62e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	1.46e-06	4.62e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.45e-06	4.6e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	1.45e-06	4.6e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	1.45e-06	4.59e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	1.45e-06	4.59e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.43e-06	4.52e-05	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.43e-06	4.52e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—INS—type 2 diabetes mellitus	1.42e-06	4.51e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.42e-06	4.5e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.42e-06	4.5e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.42e-06	4.5e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.42e-06	4.5e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.42e-06	4.49e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	1.41e-06	4.47e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	1.41e-06	4.47e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.41e-06	4.47e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	1.41e-06	4.47e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.4e-06	4.45e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	1.4e-06	4.44e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.4e-06	4.44e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.4e-06	4.44e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.39e-06	4.41e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.39e-06	4.4e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.39e-06	4.4e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	1.39e-06	4.39e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.37e-06	4.33e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.36e-06	4.32e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	1.36e-06	4.3e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.35e-06	4.29e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.35e-06	4.27e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	1.34e-06	4.26e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	1.34e-06	4.25e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.34e-06	4.25e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	1.34e-06	4.23e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.33e-06	4.22e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	1.33e-06	4.22e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.32e-06	4.17e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	1.31e-06	4.16e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	1.31e-06	4.16e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	1.31e-06	4.16e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	1.31e-06	4.15e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	1.31e-06	4.14e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	1.31e-06	4.13e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.3e-06	4.11e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	1.3e-06	4.11e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	1.29e-06	4.08e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	1.28e-06	4.07e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	1.28e-06	4.04e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	1.27e-06	4.02e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	1.27e-06	4.01e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.26e-06	3.99e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	1.26e-06	3.99e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.26e-06	3.99e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	1.26e-06	3.98e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	1.25e-06	3.97e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	1.25e-06	3.97e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	1.25e-06	3.96e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.25e-06	3.96e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	1.25e-06	3.95e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.25e-06	3.95e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	1.25e-06	3.94e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	1.24e-06	3.91e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	1.23e-06	3.9e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	1.22e-06	3.86e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	1.2e-06	3.81e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.2e-06	3.8e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	1.2e-06	3.8e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	1.19e-06	3.76e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.19e-06	3.76e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.18e-06	3.75e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	1.17e-06	3.7e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.16e-06	3.67e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.16e-06	3.67e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	1.16e-06	3.67e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.16e-06	3.67e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.16e-06	3.66e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	1.16e-06	3.66e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.15e-06	3.65e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.15e-06	3.65e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	1.15e-06	3.63e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.15e-06	3.63e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	1.15e-06	3.63e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	1.14e-06	3.62e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	1.14e-06	3.61e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	1.14e-06	3.6e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.14e-06	3.6e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.14e-06	3.6e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.14e-06	3.6e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	1.13e-06	3.59e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.13e-06	3.58e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.13e-06	3.58e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.13e-06	3.58e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	1.13e-06	3.57e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.12e-06	3.55e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	1.12e-06	3.55e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	1.12e-06	3.54e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.1e-06	3.5e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.1e-06	3.49e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	1.1e-06	3.48e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	1.09e-06	3.46e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.09e-06	3.45e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	1.09e-06	3.45e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	1.08e-06	3.43e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	1.08e-06	3.42e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	1.08e-06	3.41e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	1.08e-06	3.4e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.07e-06	3.4e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.06e-06	3.37e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	1.06e-06	3.37e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	1.06e-06	3.37e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.05e-06	3.34e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.05e-06	3.31e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.03e-06	3.27e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	1.03e-06	3.27e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.03e-06	3.26e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.02e-06	3.24e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.02e-06	3.23e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.01e-06	3.21e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.01e-06	3.21e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.01e-06	3.21e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	1.01e-06	3.21e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1e-06	3.17e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	9.94e-07	3.15e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	9.93e-07	3.14e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	9.89e-07	3.13e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	9.85e-07	3.12e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	9.81e-07	3.11e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.81e-07	3.11e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	9.81e-07	3.1e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	9.81e-07	3.1e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	9.76e-07	3.09e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	9.75e-07	3.09e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	9.64e-07	3.05e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	9.64e-07	3.05e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	9.63e-07	3.05e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	9.61e-07	3.04e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	9.5e-07	3.01e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	9.49e-07	3e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	9.41e-07	2.98e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	9.38e-07	2.97e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	9.35e-07	2.96e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.33e-07	2.95e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	9.33e-07	2.95e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	9.31e-07	2.95e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	9.27e-07	2.93e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	9.23e-07	2.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	9.2e-07	2.91e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	9.16e-07	2.9e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	9.16e-07	2.9e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	9.1e-07	2.88e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	9.02e-07	2.86e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	8.94e-07	2.83e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	8.93e-07	2.83e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	8.87e-07	2.81e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	8.84e-07	2.8e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	8.79e-07	2.78e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	8.78e-07	2.78e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	8.78e-07	2.78e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	8.76e-07	2.77e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	8.74e-07	2.77e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	8.74e-07	2.77e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	8.71e-07	2.76e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	8.66e-07	2.74e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	8.53e-07	2.7e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	8.49e-07	2.69e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	8.43e-07	2.67e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	8.38e-07	2.65e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	8.37e-07	2.65e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	8.21e-07	2.6e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	8.06e-07	2.55e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	8.06e-07	2.55e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	8.04e-07	2.55e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	7.89e-07	2.5e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	7.7e-07	2.44e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	7.64e-07	2.42e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	7.63e-07	2.42e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.57e-07	2.4e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	7.57e-07	2.4e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	7.55e-07	2.39e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	7.54e-07	2.39e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	7.52e-07	2.38e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	7.51e-07	2.38e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	7.49e-07	2.37e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	7.48e-07	2.37e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	7.44e-07	2.35e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	7.4e-07	2.34e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	7.38e-07	2.33e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	7.22e-07	2.29e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	7.2e-07	2.28e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	7.2e-07	2.28e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	7.02e-07	2.22e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	6.92e-07	2.19e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	6.89e-07	2.18e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	6.86e-07	2.17e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	6.75e-07	2.14e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	6.72e-07	2.13e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	6.62e-07	2.1e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	6.62e-07	2.1e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	6.58e-07	2.08e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	6.56e-07	2.08e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	6.56e-07	2.08e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	6.55e-07	2.07e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	6.52e-07	2.06e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	6.47e-07	2.05e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	6.4e-07	2.02e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	6.21e-07	1.96e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	6.09e-07	1.93e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	6.05e-07	1.92e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	6e-07	1.9e-05	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	5.97e-07	1.89e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	5.9e-07	1.87e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	5.86e-07	1.86e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	5.8e-07	1.84e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	5.78e-07	1.83e-05	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	5.74e-07	1.82e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	5.71e-07	1.81e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	5.61e-07	1.78e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	5.61e-07	1.78e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	5.13e-07	1.62e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	5.03e-07	1.59e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	4.94e-07	1.56e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	4.52e-07	1.43e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	4.33e-07	1.37e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	4.33e-07	1.37e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	4.29e-07	1.36e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	3.96e-07	1.25e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	3.71e-07	1.17e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	3.31e-07	1.05e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	3.04e-07	9.63e-06	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	3.02e-07	9.55e-06	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	2.58e-07	8.16e-06	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.99e-07	6.3e-06	CbGpPWpGaD
